- Home
- TNXP vs MNSB Comparison
TNXP vs MNSB Comparison
Compare TNXP & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- MNSB
- Stock Information
- Founded
- TNXP 2007
- MNSB 2003
- Country
- TNXP United States
- MNSB United States
- Employees
- TNXP N/A
- MNSB N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- MNSB Major Banks
- Sector
- TNXP Health Care
- MNSB Finance
- Exchange
- TNXP Nasdaq
- MNSB Nasdaq
- Market Cap
- TNXP 118.2M
- MNSB 118.0M
- IPO Year
- TNXP N/A
- MNSB N/A
- Fundamental
- Price
- TNXP $18.83
- MNSB $19.05
- Analyst Decision
- TNXP Strong Buy
- MNSB
- Analyst Count
- TNXP 2
- MNSB 0
- Target Price
- TNXP $585.00
- MNSB N/A
- AVG Volume (30 Days)
- TNXP 573.9K
- MNSB 25.4K
- Earning Date
- TNXP 05-20-2025
- MNSB 04-21-2025
- Dividend Yield
- TNXP N/A
- MNSB 2.10%
- EPS Growth
- TNXP N/A
- MNSB N/A
- EPS
- TNXP N/A
- MNSB N/A
- Revenue
- TNXP $10,094,000.00
- MNSB $59,896,000.00
- Revenue This Year
- TNXP $12.17
- MNSB $17.95
- Revenue Next Year
- TNXP $789.15
- MNSB $2.52
- P/E Ratio
- TNXP N/A
- MNSB N/A
- Revenue Growth
- TNXP 29.94
- MNSB N/A
- 52 Week Low
- TNXP $6.76
- MNSB $15.00
- 52 Week High
- TNXP $672.00
- MNSB $20.88
- Technical
- Relative Strength Index (RSI)
- TNXP 53.35
- MNSB 62.71
- Support Level
- TNXP $18.55
- MNSB $18.75
- Resistance Level
- TNXP $21.99
- MNSB $20.09
- Average True Range (ATR)
- TNXP 1.53
- MNSB 0.83
- MACD
- TNXP 0.22
- MNSB 0.06
- Stochastic Oscillator
- TNXP 58.64
- MNSB 69.23
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.